![]() ![]() Reduced phosphoinositide 3-kinase(p110) increases the susceptibility to atrial fibrillation. Pretorius L, Du XJ, Woodcock EA, Kiriazis H, Lin RCY, Marasco S, Medcalf RL, Ming Z, Head GA, Tan J, Cemerlang N, Sadoshima J, Shioi T, Izumo S, Dart AM, Jennings GL, McMullen JR*. PI3K and its protective effects in the failing heart.Ĭlinical Science. ![]() Promoting physiological hypertrophy in the failing heart. Pretorius L, Owen K, Jennings GL, McMullen JR*. Fibroblasts Associated with Cardiac Fibrosis Carry Endothelial Imprint: Implication for Endothelial to Mesenchymal Transition. Zeisberg EM, Tarnavski O, Zeisberg M, Dorfman A, McMullen JR, Gustafsson E, Chandraker A,Yuan X, Pu W, Roberts A, Neilson E, Sayegh M, Izumo S, Kalluri R. PI3K(p110alpha) Inhibitors as Anti-Cancer Agents: Minding the Hypertrophy: novel therapeutic strategies to treat heart failure. Differences between pathological and physiological cardiac Protective effects of exercise and PI3K(p110α) signaling in dilated and hypertrophic cardiomyopathy. McMullen JR*, Amirahmadi F,Woodcock EA, Schinke-Braun M, Bouwman RD, Hewitt KA, Mollica JP, Zhang L, Zhang Y, Shioi T, Buerger A, Izumo S, Jay PY, Jennings GL. Professor Peter Meikle (Baker Heart and Diabetes Institute)- LipidomicsĪssociate Professor Paul Gregorevic (University of Melbourne)- Gene therapy e.g. Preclinical Cardiology Microsurgery & Imaging PlatformĪssociate Professor Ruby Lin (The Westmead Institute for Medical Research)- Non-coding RNAs e.g.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |